Beta Bionics, Inc.
BBNX - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$753.58M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $753.58 Million |
|---|---|
| Enterprise Value | $717.65 Million |
| Earnings per Share | $-1.81 |
| Beta | 3.38 |
| Outstanding Shares | 46,541,997 |
Return
| Return on Equity | -32.42% |
|---|---|
| Return on Assets | -28.43% |
| Return on Invested Capital | -32.87% |
Valuation & Multiples
| P/E Ratio | -8.96 |
|---|---|
| PEG | -12.55 |
| Price to Sales | 8.38 |
| Price to Book Ratio | 3.35 |
| Enterprise Value to Revenue | 5.64 |
| Enterprise Value to EBIT | -8.2 |
| Enterprise Value to Net Income | -9 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Last Earnings Call
Report Date
October 27, 2026
EPS Estimate
$-0.52
Consensus analyst estimateRevenue Estimate
$34.72 M
Consensus analyst estimateNext Earnings Call
Expected Date
February 16, 2027
EPS Estimate
$-0.50
Consensus analyst estimateRevenue Estimate
$31.14 M
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.35%▼ 108.19% |
|---|---|
| Total Invested | $2.97M▼ 99.61% |
| Investors Holding | 22▼ 116.00% |
About Beta Bionics, Inc.
422 employees
CEO: Sean T. Saint
Beta Bionics, Inc. is a commercial-stage medical technology company dedicated to inventing, developing, and bringing to market solutions that improve the health and quality of life for individuals with diabetes who depend on insulin. The...